American Century Companies’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-141,986
| Closed | -$227K | – | 2867 |
|
|
2025
Q1 | $227K | Buy |
141,986
+9,154
| +7% | +$14.6K | ﹤0.01% | 2732 |
|
|
2024
Q4 | $478K | Buy |
132,832
+10,459
| +9% | +$37.7K | ﹤0.01% | 2527 |
|
|
2024
Q3 | $698K | Buy |
122,373
+12,298
| +11% | +$70.1K | ﹤0.01% | 2360 |
|
|
2024
Q2 | $509K | Buy |
110,075
+21,225
| +24% | +$98.1K | ﹤0.01% | 2432 |
|
|
2024
Q1 | $726K | Buy |
88,850
+54,116
| +156% | +$442K | ﹤0.01% | 2282 |
|
|
2023
Q4 | $196K | Buy |
34,734
+2,938
| +9% | +$16.6K | ﹤0.01% | 2701 |
|
|
2023
Q3 | $59.1K | Buy |
31,796
+7,843
| +33% | +$14.6K | ﹤0.01% | 2788 |
|
|
2023
Q2 | $65.9K | Buy |
23,953
+9,292
| +63% | +$25.6K | ﹤0.01% | 2745 |
|
|
2023
Q1 | $45.4K | Buy |
14,661
+2,675
| +22% | +$8.29K | ﹤0.01% | 2632 |
|
|
2022
Q4 | $70.7K | Buy |
+11,986
| New | +$70.7K | ﹤0.01% | 2505 |
|